Drug intelligence / Profile preview

MicroRepair ABX

Development stage: Preclinical
Lead developer: Coswell
Modality: Small Molecules
Administration: Topical

Overview

**MicroRepair ABX** is a Coswell oral-care antimicrobial and enamel-protective mouthwash technology used in the Biorepair Plus antibacterial mousse mouthwash. It combines cetylpyridinium chloride, magnolol, honokiol, and biomimetic hydroxyapatite microcrystals. Cetylpyridinium chloride provides broad antimicrobial activity, while the hydroxyapatite component adheres to dental surfaces to form a protective mineral barrier that reduces bacterial adhesion, proliferation, and biofilm formation. It has been evaluated as an adjunct to professional biofilm removal for generalized plaque-induced gingivitis.

Brand names: MicroRepair ABX
Other names: MicrorepairABX

Targets

Bacterial cell surface and biofilm matrix

Beyond the preview

Go deeper on MicroRepair ABX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRepair ABX.

Explore the full profile